CD34 and osteosarcoma: Since mice have different VγVδ T-cell sets than humans [11], to verify whether NZ could reverse chemo-immune-resistance in preclinical models of osteosarcoma, we used Hu-CD34+ mice, characterized by functional Vγ9δ2 T-lymphocytes [30].